American International Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-17,624
| Closed | -$684K | – | 605 |
|
|
2024
Q1 | $684K | Sell |
17,624
-1,139
| -6% | -$39.9K | ﹤0.01% | 1504 |
|
|
2023
Q4 | $578K | Sell |
18,763
-259
| -1% | -$6.49K | ﹤0.01% | 1582 |
|
|
2023
Q3 | $425K | Buy |
19,022
+413
| +2% | +$9.42K | ﹤0.01% | 1695 |
|
|
2023
Q2 | $400K | Buy |
18,609
+259
| +1% | +$5.88K | ﹤0.01% | 1787 |
|
|
2023
Q1 | $440K | Buy |
18,350
+82
| +0.4% | +$2.17K | ﹤0.01% | 1667 |
|
|
2022
Q4 | $424K | Sell |
18,268
-351
| -2% | -$7.08K | ﹤0.01% | 1691 |
|
|
2022
Q3 | $298K | Buy |
18,619
+214
| +1% | +$3.77K | ﹤0.01% | 1909 |
|
|
2022
Q2 | $326K | Sell |
18,405
-1,375
| -7% | -$23.1K | ﹤0.01% | 1864 |
|
|
2022
Q1 | $403K | Sell |
19,780
-1,212
| -6% | -$22.9K | ﹤0.01% | 1846 |
|
|
2021
Q4 | $392K | Sell |
20,992
-1,126
| -5% | -$21.9K | ﹤0.01% | 1966 |
|
|
2021
Q3 | $437K | Sell |
22,118
-741
| -3% | -$16K | ﹤0.01% | 1948 |
|
|
2021
Q2 | $540 | Sell |
22,859
-37
| -0.2% | -$855 | ﹤0.01% | 1873 |
|
|
2021
Q1 | $543 | Buy |
22,896
+2,941
| +15% | +$69.9K | ﹤0.01% | 1787 |
|
|
2020
Q4 | $400 | Sell |
19,955
-573
| -3% | -$11.2K | ﹤0.01% | 1875 |
|
|
2020
Q3 | $427K | Sell |
20,528
-466
| -2% | -$8.41K | ﹤0.01% | 1669 |
|
|
2020
Q2 | $367K | Buy |
20,994
+1,968
| +10% | +$38.5K | ﹤0.01% | 1757 |
|
|
2020
Q1 | $311K | Sell |
19,026
-1,099
| -5% | -$22.7K | ﹤0.01% | 1664 |
|
|
2019
Q4 | $414K | Sell |
20,125
-170
| -0.8% | -$2.83K | ﹤0.01% | 1798 |
|
|
2019
Q3 | $233K | Sell |
20,295
-141
| -0.7% | -$1.61K | ﹤0.01% | 2077 |
|
|
2019
Q2 | $269K | Buy |
20,436
+1,723
| +9% | +$23K | ﹤0.01% | 2043 |
|
|
2019
Q1 | $283K | Sell |
18,713
-607
| -3% | -$9.72K | ﹤0.01% | 2016 |
|
|
2018
Q4 | $332K | Sell |
19,320
-148
| -0.8% | -$2.53K | ﹤0.01% | 1888 |
|
|
2018
Q3 | $287K | Buy |
19,468
+350
| +2% | +$6.2K | ﹤0.01% | 2201 |
|
|
2018
Q2 | $456K | Buy |
19,118
+3,101
| +19% | +$76.2K | ﹤0.01% | 1897 |
|
|
2018
Q1 | $409K | Sell |
16,017
-862
| -5% | -$20.5K | ﹤0.01% | 1854 |
|
|
2017
Q4 | $312K | Buy |
16,879
+1,681
| +11% | +$24.1K | ﹤0.01% | 2059 |
|
|
2017
Q3 | $159K | Buy |
15,198
+1,137
| +8% | +$12.5K | ﹤0.01% | 2414 |
|
|
2017
Q2 | $176K | Buy |
14,061
+4,113
| +41% | +$40.6K | ﹤0.01% | 2346 |
|
|
2017
Q1 | $100K | Buy |
9,948
+2,163
| +28% | +$32.2K | ﹤0.01% | 2591 |
|
|
2016
Q4 | $121K | Sell |
7,785
-21
| -0.3% | -$349 | ﹤0.01% | 2488 |
|
|
2016
Q3 | $150K | Buy |
7,806
+11
| +0.1% | +$131 | ﹤0.01% | 2358 |
|
|
2016
Q2 | $92.4K | Buy |
7,795
+3,889
| +100% | +$64.2K | ﹤0.01% | 2667 |
|
|
2016
Q1 | $71K | Hold |
3,906
| – | – | ﹤0.01% | 3660 |
|
|
2015
Q4 | $107K | Sell |
3,906
-7
| -0.2% | -$147 | ﹤0.01% | 3432 |
|
|
2015
Q3 | $87K | Buy |
3,913
+4
| +0.1% | +$72 | ﹤0.01% | 3587 |
|
|
2015
Q2 | $69.7K | Buy |
+3,909
| New | +$67.6K | ﹤0.01% | 3896 |
|
Other funds holding COLL
EAM
RCMNY
American International Group's COLL Position: Q2 2024 in Review
American International Group sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 17,624 shares — an estimated $684K sold.
American International Group first reported a position in COLL in Q2 2015 and held it in 36 quarters. The position peaked at $684K in Q1 2024. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.
- American International Group reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
- American International Group sold 17,624 Collegium Pharmaceutical shares in Q2 2024, an estimated $684K.
- American International Group first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 36 quarters.
- American International Group's Collegium Pharmaceutical position peaked at $684K in Q1 2024.
- 229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.